Your browser doesn't support javascript.
loading
Open-label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC versus the combination of paclitaxel and everolimus followed by FEC in women with triple receptor-negative breast cancer†.
Gonzalez-Angulo, A M; Akcakanat, A; Liu, S; Green, M C; Murray, J L; Chen, H; Palla, S L; Koenig, K B; Brewster, A M; Valero, V; Ibrahim, N K; Moulder-Thompson, S; Litton, J K; Tarco, E; Moore, J; Flores, P; Crawford, D; Dryden, M J; Symmans, W F; Sahin, A; Giordano, S H; Pusztai, L; Do, K-A; Mills, G B; Hortobagyi, G N; Meric-Bernstam, F.
Affiliation
  • Gonzalez-Angulo AM; Department of Breast Medical Oncology Department of Systems Biology agonzalez@mdanderson.org.
  • Akcakanat A; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston.
  • Liu S; Department of Breast Medical Oncology.
  • Green MC; Genenetech, San Francisco.
  • Murray JL; Department of Breast Medical Oncology.
  • Chen H; Department of Breast Medical Oncology.
  • Palla SL; Departments of Biostatistics.
  • Koenig KB; Department of Breast Medical Oncology.
  • Brewster AM; Clinical Cancer Prevention.
  • Valero V; Department of Breast Medical Oncology.
  • Ibrahim NK; Department of Breast Medical Oncology.
  • Moulder-Thompson S; Department of Breast Medical Oncology.
  • Litton JK; Department of Breast Medical Oncology.
  • Tarco E; Department of Breast Medical Oncology.
  • Moore J; Department of Breast Medical Oncology.
  • Flores P; Department of Breast Medical Oncology.
  • Crawford D; Department of Breast Medical Oncology.
  • Dryden MJ; Radiology.
  • Symmans WF; Pathology, The University of Texas MD Anderson Cancer Center, Houston.
  • Sahin A; Pathology, The University of Texas MD Anderson Cancer Center, Houston.
  • Giordano SH; Department of Breast Medical Oncology.
  • Pusztai L; Division of Hematology-Oncology, Yale University, New Haven.
  • Do KA; Departments of Biostatistics.
  • Mills GB; Department of Systems Biology.
  • Hortobagyi GN; Department of Breast Medical Oncology.
  • Meric-Bernstam F; Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, USA.
Ann Oncol ; 25(6): 1122-7, 2014 Jun.
Article in En | MEDLINE | ID: mdl-24669015
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Neoadjuvant Therapy / Triple Negative Breast Neoplasms Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2014 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Neoadjuvant Therapy / Triple Negative Breast Neoplasms Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2014 Document type: Article